Search Browse Earnings

Semnur Pharmaceuticals, Inc. — SlamSEC

Semnur Pharmaceuticals, Inc.

OTC:SMNROTC:SMNRW

Pharmaceutical Preparations·PALO ALTO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$50.0M

FY 2024

Adj. EBITDA

-$4.7M

-9.4% margin

FY 2025

Net Income

-$4.7M

-9.4% margin

FY 2025

EPS (Diluted)

-$0.02

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$12,000

FY 2025

Total Debt

—

Net Cash

$12,000

FY 2025

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

—

Employees

—